Trials / Not Yet Recruiting
Not Yet RecruitingNCT07168941
Evaluation and Refinement of KF-STRIDE Into the Interview!
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Kessler Foundation · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Examine the acceptability, usability, feasibility, and initial efficacy of KF-STRIDE 3.0, the data from which will serve as a basis for a future fully powered RCT
Detailed description
Although KF-STRIDE 2.0 was designed to support youth on the spectrum, its current design may not be appropriate for adults. Thus, the current proposal will support development activities to significantly adapt KF-STRIDE 2.0 to meet the specific needs of adults with autism. As part of development, we will partner with the autism community, using mixed methodology to ensure our modifications are performed with community-engaged methods. We will invite adults with autism, family members, employers, and vocational counselors to provide feedback to guide the modifications to KF-STRIDE. We will then test the acceptability, feasibility, fidelity, and initial efficacy of KF-STRIDE 3.0 among adults on the spectrum. Obtaining employment is essential to individuals on the spectrum as it can lead to improved community integration, increased social networking, and a means to contribute to society as productive citizens. Overall, we propose to adapt a treatment that has strong potential to help adults with autism improve their job interview skills that will lead to increased employment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | KF-STRIDE | KF Stride works to improve identification (awareness) of personal character strengths and 2) express them in a socially appropriate way during a job interview |
Timeline
- Start date
- 2025-10-01
- Primary completion
- 2026-09-10
- Completion
- 2026-10-01
- First posted
- 2025-09-11
- Last updated
- 2025-09-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07168941. Inclusion in this directory is not an endorsement.